Mark S. Smeltzer profile photo

Mark S. Smeltzer Institution-verified

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy Federal Grant PI High Impact

Infectious Disease Research - UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses

Last publication 2026 Last refreshed 2026-05-22

faculty

Microbiology & Immunology, College of Medicine

55 h-index 167 pubs 11,055 cited

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Mark S. Smeltzer is a researcher at the University of Arkansas for Medical Sciences (UAMS) within the Infectious Disease Research division of the Center for Microbial Pathogenesis and Host Inflammatory Responses, and the Department of Microbiology & Immunology.

His research focuses on the pathogenesis of *Staphylococcus aureus* infections, particularly those involving biofilms. Smeltzer investigates the mechanisms by which *S. aureus* causes disease, including the role of virulence factors such as proteases. His work has explored the genetic regulation of these factors, including the impact of mutations in genes like *purR* and *sarA* on protease production and overall virulence. He has also examined host responses, such as osteoclast formation mediated by RANKL in the context of osteomyelitis.

Smeltzer's work has been supported by federal grants, and he has published extensively on these topics. His h-index is 54 with over 10,900 citations. He collaborates with several researchers at UAMS, including Karen E. Beenken and Mara J. Campbell, with whom he has co-authored numerous publications. Smeltzer leads a research group and maintains an active lab website.

Metrics

  • h-index: 55
  • Publications: 167
  • Citations: 11,055

Selected Publications

  • Lipolysis of host triacylglyceride-rich lipoproteins creates a toxic microenvironment for <i>Staphylococcus aureus</i> (2026)
  • Staphylococcus aureus Biofilm-Associated Infections: Have We Found a Clinically Relevant Target? (2025)
    11 citations DOI OpenAlex
  • Staphylococcus aureus Proteins Implicated in the Reduced Virulence of sarA and sarA/agr Mutants in Osteomyelitis (2025)
    5 citations DOI OpenAlex
  • The ability of <i>sarA</i> to limit protease production plays a key role in the pathogenesis of <i>Staphylococcus aureus</i> osteomyelitis irrespective of the functional status of <i>agr</i> (2024)
    10 citations DOI OpenAlex
  • RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis (2024)
    14 citations DOI OpenAlex
  • Increased production of aureolysin and staphopain A is a primary determinant of the reduced virulence of <i>Staphylococcus aureus sarA</i> mutants in osteomyelitis (2024)
    11 citations DOI OpenAlex
  • Comparative evaluation of small molecules reported to be inhibitors of <i>Staphylococcus aureus</i> biofilm formation (2023)
    6 citations DOI OpenAlex
  • The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production is correlated with decreased virulence in diverse clinical isolates in osteomyelitis (2022)
  • Pyroptosis and pyroptosis-inducing cancer drugs (2022)
    141 citations DOI OpenAlex
  • Is amplification bias consequential in transposon sequencing (TnSeq) assays? A case study with a Staphylococcus aureus TnSeq library subjected to PCR-based and amplification-free enrichment methods (2021)
    2 citations DOI OpenAlex
  • Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect (2021)
    21 citations DOI OpenAlex
  • 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents (2021)
    25 citations DOI OpenAlex
  • Limiting protease production plays a key role in the pathogenesis of the divergent clinical isolates of <i>Staphylococcus aureus</i> LAC and UAMS-1 (2021)
    15 citations DOI OpenAlex
  • Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone (2021)
    2 citations DOI OpenAlex
  • The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a <i>purR</i> Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases (2021)
    12 citations DOI OpenAlex

View all publications on OpenAlex →

ARA Academy 2017 ARA Fellow

Dr. Smeltzer dedicates his research to combating Staphylococcus aureus, a bacterial pathogen responsible for approximately 20,000 American deaths annually. He focuses on bone infections and those involving indwelling orthopaedic devices. He also serves as Program Director of a COBRE promoting infectious disease research capacity at UAMS and central Arkansas.

Policy Impact

Leads a COBRE center promoting infectious disease research capacity in central Arkansas, generating NIH institutional funding and training biomedical researchers.

Growth Areas

['Population Health Innovations & Clinical Research']

Federal Grants 3 $1,777,311 total

NIH/National Institute of General Medical Sciences Contact PI May 2022 - Apr 2027

Center for Microbial Pathogenesis and Host Inflammatory Responses

National Institute of General Medical Sciences $1,140,000 P30
NIH/National Institute of Allergy and Infectious Diseases Contact PI Jun 2015 - Aug 2026

Defining the role of post-translational regulation by extracellular proteases in the pathogenesis of Staphylococcus aureus osteomyelitis

National Institute of Allergy and Infectious Diseases $451,739 R01
NIH/National Institute of General Medical Sciences Contact PI Aug 2012 - Apr 2023

Shared Resource to Investigate Cellular Metabolism

National Institute of General Medical Sciences $185,572 P20

Research Interests

Staphylococcus aureus, Staphylococcal infection, Osteomyelitis, Biofilm, Regulation

Grants & Funding

  • sarA as a Target for the Treatment and Prevention of Staphylococcal Biofilm-Associated Infection US Department of the Army Principal Investigator
  • sar-mediated regulation in Staphylococcus aureus NIH Principal Investigator
  • Capsule regulatory network in S. aureus pathogenesis NIH Co-Investigator
  • Center for Microbial Pathogenesis and Host Inflammatory Responses NIH Principal Investigator
  • Biofilm Dissemination in Staphylococcus aureus NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Southern Mississippi Principal Investigator
  • Center for Microbial Pathogenesis and Host Inflammatory Responses NIH/Nat. Inst. of General Medical Sciences Principal Investigator
  • Investigating a Flexible, Degradable Local Antimicrobial Delivery System - Continuation - Continuation DHHS - Biomedical Advanced Research and Development Authority - Pass Through: University of Memphis Principal Investigator
  • Chitosan films for prevention of wound infections US Department of the Army Principal Investigator

Collaboration Network

76 Collaborators 15 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics